Incregen Therapeutics
PrivateCompany Overview
Incregen Therapeutics operates in Healthcare & Life Sciences and is based in New Jersey. It was founded in 2023.
Incregen Therapeutics is a biotechnology company developing novel therapies for obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Incregen Therapeutics Comparables
Compare Incregen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helicore Biopharma | 91% |
For institutional investors. Book with your work email.
Incregen Therapeutics Funding Rounds
Historical fundraising activity
Incregen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Incregen Therapeutics's valuation, stock price, and market status.
Is Incregen Therapeutics a public or private company?
Incregen Therapeutics is a private company.
What is the current stock price of Incregen Therapeutics?
Incregen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Incregen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Incregen Therapeutics worth (valuation)?
Valuation information for Incregen Therapeutics is not publicly available.
Can I buy Incregen Therapeutics stock?
Incregen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Incregen Therapeutics's last funding round?
Funding round information for Incregen Therapeutics is not publicly available.
Who are the main investors in Incregen Therapeutics?
Investor information for Incregen Therapeutics is not publicly disclosed.
Will Incregen Therapeutics IPO soon?
No public IPO plans have been announced for Incregen Therapeutics.
How can I track Incregen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Incregen Therapeutics's shares on secondary markets.